Abridge, an AI startup automating medical notes, has raised $300 million in a Series E funding round, elevating its valuation to $5.3 billion. The investment round led by Andreessen Horowitz follows a prior $250 million round in February. Abridge is recognized as a frontrunner in the AI medical scribe sector, benefiting from its partnership with Epic Systems. The company reported $117 million in contracted annual recurring revenue and is enhancing its offerings by entering AI medical coding, intensifying competition with other tech players.
Abridge, an AI startup specializing in medical note automation, secured a $300 million Series E funding round at a valuation of $5.3 billion.
The company’s competitive edge lies in its integration with Epic Systems, positioning it as a leader in the AI medical scribe market.
Abridge's expansion into AI-driven medical coding directly competes with existing players, signaling its aggressive growth strategy in the healthcare space.
With $117 million in annual recurring revenue, Abridge showcases robust growth and solidifies its position among the leading health technology firms.
Collection
[
|
...
]